Athérothrombose : transposition des modèles à la clinique et réciproquement

Therapies - Tập 61 - Trang 389-394 - 2006
Christian Gachet1,2,3, Béatrice Hechler1,2,3, Christelle Nonne2,3, Jean-Pierre Cazenave1,2,3, François Lanza2,3, Boris Aleil1,2,3
1EFS Alsace, Strasbourg, France
2INSERM, U311 Strasbourg, France
3Université Louis Pasteur, Strasbourg, France

Tài liệu tham khảo

Cazenave, 1983, L’agrégation plaquettaire: outil d’investigation clinique et d’étude pharmacologique. Méthodologie, Ann Biol Clin, 41, 167

Boneu, 1997, Introduction à l’étude de l’hémostase et de la thrombose

Leon, 1997, The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells, FEBS Lett, 403, 26, 10.1016/S0014-5793(97)00022-7

Hechler, 1998, The P2Y1 receptor is necessary for adenosine 5’-diphosphate-induced platelet aggregation, Blood, 92, 152, 10.1182/blood.V92.1.152.413k27_152_159

Nonne, 2005, Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity, Arterioscler Thromb Vasc Biol, 25, 1293, 10.1161/01.ATV.0000163184.02484.69

Mizuno, 1992, Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes, N Engl J Med, 326, 287, 10.1056/NEJM199201303260502

TIMI IIIb Trial, 1994, Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction, Circulation, 89, 1545, 10.1161/01.CIR.89.4.1545

Lanza, 2000, La glycoprotéine V: un substrat plaquettaire de la thrombine marqueur des thromboses et de la différenciation mégacaryocytaire, Hématologie, 6, 424

Aleil, 2004, La glycoprotéine V soluble: un nouveau marqueur plasmatique de la thrombose artérielle, MT cardiologie, 2, 267